Amoxicillin (AMX) is a semisynthetic
antibiotic, an analogue of
ampicillin, with a wide spectrum of bacterial activity against many
microorganisms but possesses some limits. To increase the drug effectiveness,
supramolecule nanocomposites composed of β-cyclodextrin (β-CD)
and chitosan/sodium alginate/GO were chosen in the present study as
a sustained release formulation. Nanocomposites of chitosan (CH),
sodium alginate (ALG), and graphene oxide (GO) were synthesized at
50 °C. The inclusion complexes (ICs) were processed via the physical
mixture (PM), kneading (KM), microwave (MW) method, or coprecipitation
(CP) and directly loaded into the nanocomposite. To confirm the formation
of true ICs, the ICs were analyzed by DSC, SEM, 1H NMR,
2D NMR ROESY, and XRD. A drug release study was performed to find
out which method is best for the controlled release of drugs in different
environments of pH 2, 7, and 7.4 at 37 °C. From the observed
drug release data, it was found that PM and KM showed a burst release
of drugs and the microwave method was the most suitable method to
prepare exact ICs of AMX and β-CD for sustained release of drugs.
Kinetics of drug release was analyzed by various kinetic models, and
it was observed that the Korsmeyer–Peppas and Peppas–Sahlin
models were best fit for drug release in all cases. A Phase solubility
study was carried out to find the stoichiometry of IC formation and
the complexation constant. The drug release was controlled and pH-dependent,
confirming that nanocomposites are pH-sensitive. From drug release
analysis, it was acknowledged that β-CD is capable of causing
sustained drug release.